Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuwei He

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Rheumatology (Oxford, England)|November 6, 2024
An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievementHan Qi, Jie Lu, Nicola Dalbeth, et al.
Seminars in Arthritis and Rheumatism|February 29, 2024
The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapyLin Han, Runze Li, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|November 19, 2020
The efficacy and safety of citrate mixture vs sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled studyXiaomei Xue, Zhen Liu, Xinde Li, et al.
Arthritis Research & Therapy|January 26, 2022
Association of acidic urine pH with impaired renal function in primary gout patients: a Chinese population-based cross-sectional studyYuwei He, Xiaomei Xue, Robert Terkeltaub, et al.
Rheumatology (Oxford, England)|March 11, 2021
Effects of fenofibrate therapy on renal function in primary gout patientsXinde Li, Wenyan Sun, Jie Lu, et al.
Rheumatology (Oxford, England)|November 21, 2022
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort studyShuhui Hu, Mingshu Sun, Maichao Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 7, 2022
Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid UnderexcretionFei Yan, Xiaomei Xue, Jie Lu, et al.
Iscience|July 26, 2024
Epidermal growth factor augments the self-renewal capacity of aged hematopoietic stem cellsVivian Y Chang, Yuwei He, Samantha Grohe, et al.
International Journal of Rheumatic Diseases|August 25, 2025
2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common ComorbiditiesChanggui Li, Mingshu Sun, Zhen Liu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2024
Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout CohortAichang Ji, Yang Sui, Xiaomei Xue, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|November 6, 2024
An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievementHan Qi, Jie Lu, Nicola Dalbeth, et al.
Seminars in Arthritis and Rheumatism|February 29, 2024
The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapyLin Han, Runze Li, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|November 19, 2020
The efficacy and safety of citrate mixture vs sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled studyXiaomei Xue, Zhen Liu, Xinde Li, et al.
Arthritis Research & Therapy|January 26, 2022
Association of acidic urine pH with impaired renal function in primary gout patients: a Chinese population-based cross-sectional studyYuwei He, Xiaomei Xue, Robert Terkeltaub, et al.
Rheumatology (Oxford, England)|March 11, 2021
Effects of fenofibrate therapy on renal function in primary gout patientsXinde Li, Wenyan Sun, Jie Lu, et al.
Rheumatology (Oxford, England)|November 21, 2022
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort studyShuhui Hu, Mingshu Sun, Maichao Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 7, 2022
Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid UnderexcretionFei Yan, Xiaomei Xue, Jie Lu, et al.
Iscience|July 26, 2024
Epidermal growth factor augments the self-renewal capacity of aged hematopoietic stem cellsVivian Y Chang, Yuwei He, Samantha Grohe, et al.
International Journal of Rheumatic Diseases|August 25, 2025
2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common ComorbiditiesChanggui Li, Mingshu Sun, Zhen Liu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2024
Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout CohortAichang Ji, Yang Sui, Xiaomei Xue, et al.
Pageof 13